top of page
Meet the Amplio Pharma team
Marguerite Mensonides
CEO
Bart Wuurman
Director Business Development
Karin von Wachenfeldt
Director Clinical
Charlott Brunmark
Chief Scientific Officer
Curtis Sprouse
Chief Strategy Officer
Supervisory Board (RvC)
Rob Mayfield, Chair
Director Libertatis Ergo Holding
Marc Roelofs
IM AUMC Venture Holding
Carmen van Vilsteren
Director Imigion
Scientific Advisory Board
Prof. Joel Kremer, MD
KOL rheumatology USA
Founder Corrona Research Foundation
Prof. Michael Weinblatt
KOL rheumatology USA
Brigham and Women's Hospital
Prof. Stanley Cohen
KOL rheumatologoy USA
U of TX Southwestern Medical School
Prof. Robert de Jonge, MD
KOL Lab Medicine NL
Amsterdam UMC
Maja Bulatovic, MD
KOL immunology NL
Amsterdam and Utrecht UMCs
Market Access Advisory Board
Henrik Fenger
VP Photonamic
Lars Bukhave-Rasmussen
CEO Bio2Pharma
bottom of page